Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team.
about
First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacyRectal pre-exposure prophylaxis (PrEP)Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologiesPrevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gelOverview of microbicides for the prevention of human immunodeficiency virus.Men in methadone maintenance versus psychosocial outpatient treatment: differences in sexual risk behaviors and intervention effectiveness from a multisite HIV prevention intervention trial.Computerized counseling reduces HIV-1 viral load and sexual transmission risk: findings from a randomized controlled trialHow common and frequent is heterosexual anal intercourse among South Africans? A systematic review and meta-analysis.Correlates of anal intercourse vary by partner type among substance-using women: baseline data from the UNITY study.Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment.Factors associated with event level anal sex and condom use during anal sex among adolescent women.Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study.Sex under the influence of drugs or alcohol: common for men in substance abuse treatment and associated with high-risk sexual behavior.Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men.Correlates of heterosexual anal intercourse among substance-using club-goers.HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention.Prescription medication misuse among HIV-infected individuals taking antiretroviral therapySexual risk behavior and sex under the influence: an event analysis of men in substance abuse treatment who have sex with women.The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques.Sex-Related Alcohol Expectancies Among African American Women Attending an Urban STI ClinicHeterosexual anal sex among female sex workers in high HIV prevalence states of India: need for comprehensive interventionWhy women engage in anal intercourse: results from a qualitative studyIs monogamy or committed relationship status a marker for low sexual risk among men in substance abuse treatment? Clinical and methodological considerationsPharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques.Relationship characteristics associated with anal sex among female drug users.Using sexually transmitted infection biomarkers to validate reporting of sexual behavior within a randomized, experimental evaluation of interviewing methods.TECNOLOGÍAS DE INFORMACIÓN Y COMUNICACIÓN PARA LA PREVENCIÓN Y CONTROL DE LA INFECCIÓN POR EL VIH Y OTRAS ITS.Anal intercourse and HIV risk among low-income heterosexual women: findings from Chicago HIV behavioral surveillance.Prevalence and risk factors associated with female anal sex in the context of HIV/AIDS in the selected districts of Tanzania.A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.Antiviral activity of retrocyclin RC-101, a candidate microbicide against cell-associated HIV-1Broadly Neutralizing Anti-HIV Antibodies Prevent HIV Infection of Mucosal Tissue Ex VivoDifferences between men and women in condom use, attitudes, and skills in substance abuse treatment seekers.Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anusPredictors of condom use among men enrolled in drug treatment programsThe relationship between recent alcohol use and sexual behaviors: gender differences among sexually transmitted disease clinic patientsSexual behavior and STI/HIV status among adolescents in rural Malawi: an evaluation of the effect of interview mode on reporting.Anal intercourse among young heterosexuals in three sexually transmitted disease clinics in the United States.Partner relationships and HIV risk behaviors among women offenders.Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men.
P2860
Q21135264-A8C46B4A-E3EB-45A5-AC26-3C69602707BFQ26829713-B3A1063C-2DDC-42FA-9A21-4F8923419A1DQ27026257-147770DC-6117-4FF7-ABD7-7F9DB16081D9Q28473376-A166E38C-F8EB-4AA5-9994-AC821EFD00E2Q30413777-75FCDD78-4145-4FDB-BEF3-F1039A422F0FQ30495573-2E702FF1-9F32-4BCE-AB70-B9923B225BFFQ30576961-FEAC24F9-B592-466F-A7F4-3AF26C1C530AQ30854994-0B226F2F-0E7F-4AAB-B722-91CA7474FC30Q31165098-25F95302-426D-4A3D-ABD1-209917F9EFABQ33599628-D9E98AD2-D832-450D-9B5A-1608618F66DBQ33669106-E4A21165-4932-4064-83ED-BF2274600F09Q33798336-7AF4E4DE-A1FE-4CAB-B9E0-8F55D361EED1Q33817697-9CFDDAAC-4752-44FF-8EA8-5890AC8BE67DQ33833859-ECD35A28-4A95-4087-B960-5E281BFD62B8Q33931309-16706ED4-7AF7-4E01-B247-F9AACBB7BAB9Q34088757-56393056-9F17-436E-9EA6-D60B4214D058Q34602717-7042B5BE-258D-486E-BBE2-8AB10A8B9613Q34778302-AEB9E273-69F0-4889-A418-56C0BFD41BEEQ34982693-EA06DBC6-7770-4499-952C-FCEEC31C4A07Q35072581-84866CD5-84A0-478A-8C72-E6F3AC2782DAQ35106358-9A24FE51-B291-494C-B064-B57A05BD47F5Q35232318-64417073-0356-4FC5-8C3B-0B30D8825BD7Q35615816-CFE2AB71-E18D-4B09-B69B-DDF37168CE34Q35666402-788211E7-FC7C-4517-A057-55CCF361281FQ35755030-33BA4BAF-8E39-4DA0-A896-0E62775820A7Q35792083-E57BA4FB-4CC2-4CB8-9EE5-D5CF5FDC266EQ36016307-A93C980D-446F-4188-AEC5-56F49B2D600EQ36292490-CC9AAB85-112E-4B94-A76D-896330DC8464Q36324445-B3CAD1CA-3C69-4128-9ED7-3AC9D625F011Q36359120-668AA24B-E49E-41D3-898E-2F1DF851CB78Q36553945-7F011CB4-25F9-4FD2-8B31-5E8C212F8EC9Q36571900-61237104-0CAB-4D00-8453-15B57D6471D6Q36622867-45A148E9-243A-4EBB-9965-80B26C39DA52Q36930438-AEF29290-4619-451F-8907-1A83457E5D5DQ36945688-6BFB50BB-1BE1-4589-B8AE-D0052810032FQ36986655-6697FDB5-FA5A-4A4C-8C0D-43CCF558D94BQ37161403-65ECBC1B-F987-4A02-9B46-B3D68810FD7CQ37249738-F3F15902-8774-4039-9AA0-54B9E58C560CQ37352383-3ECFA885-43C8-43C7-AAEB-E8CBBCFCBAF6Q37358978-60344F6E-1309-43D9-BE52-43F69B90F4E9
P2860
Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Anal sex among HIV-seronegativ ...... redness Study 2 Protocol Team.
@ast
Anal sex among HIV-seronegativ ...... redness Study 2 Protocol Team.
@en
type
label
Anal sex among HIV-seronegativ ...... redness Study 2 Protocol Team.
@ast
Anal sex among HIV-seronegativ ...... redness Study 2 Protocol Team.
@en
prefLabel
Anal sex among HIV-seronegativ ...... redness Study 2 Protocol Team.
@ast
Anal sex among HIV-seronegativ ...... redness Study 2 Protocol Team.
@en
P2093
P1476
Anal sex among HIV-seronegativ ...... redness Study 2 Protocol Team.
@en
P2093
P304
P356
10.1097/00126334-200008010-00015
P407
P577
2000-08-01T00:00:00Z